A highly active Angiopoietin 1 mimetic enhances angiogenesis in mouse models of choroidal neovascularization, suggesting potential for nvAMD treatment.
Does a highly active Angiopoietin 1 mimetic potentiate angiogenesis in mouse models of choroidal neovascularization?
Understanding the contexts of Tie2 activation is critical for developing new drugs for neovascular age-related macular degeneration.
Understanding the contexts under which Tie2 activation is beneficial and where it is harmful will be critical to successful development of new Tie2-activating drugs for nvAMD.
Youssif et al. (2026) studied this question. A highly active Angiopoietin 1 mimetic enhances angiogenesis in mouse models of choroidal neovascularization, suggesting potential for nvAMD treatment.